Optimization of protected hydroxamic acids with aliphatic spacers
Scheme S1. Overview over the synthesis attempts to yield protected hydroxamic acids with C 4 and C 3 aliphatic spacers. Characterization of 2-(4-(5,5-dimethyl-1,4,2-dioxazol-3-yl)phenoxy)ethan-1-ol (1c) "HAA-OH" T-Cell proliferation assay and MTT metabolic activity analysis Figure S24 . MTT metabolic activity assay. In all cases no significant decrease in metabolic activity, translating to cell toxicity can be observed. Only in case of low MW HA "HA-OH" (1b) a subtle decrease in metabolic activity was detected, suggesting increased toxicity compared to HA-PEG 188 . (Data denote the mean±SEM of values obtained for PBMC prepared from 4 different healthy donors and tested in triplicates.) Figure S25 . T-Cell proliferation assay. Human PBMC were stimulated with PHA to induce proliferation of T-cells in the presence of the different test compounds. In case of Desferal, proliferation was completely inhibited. Low MW HA compound "HA-OH" (1b) showed dose-dependent inhibition of proliferation. In contrast, no influence of HAA-PEG or HA-PEG was found regarding T-cell proliferation. (Data denote the mean±SEM of values obtained for PBMC prepared from 4 different healthy donors and tested in triplicates.)
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